HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

UCLA receives nearly $14 million NIH grant to investigate immunotherapy to destroy HIV

UCLA researchers and colleagues have received a $13.65 million grant from the National Institutes of Health to investigate and further develop an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy HIV.

16 Jun 2020

Old antibiotic may be a powerful new tool against deadly superbug

USC researchers have discovered that an old antibiotic may be a powerful new tool against a deadly superbug, thanks to an innovative screening method that better mimics conditions inside the human body.

8 Jun 2020

KHN’s ‘What the Health?’: Protests and the pandemic

Following the death of George Floyd while in custody in Minneapolis, protests have mushroomed around the U.S. to decry police violence, raising concerns among public health officials about the potential for further spread of the coronavirus.

4 Jun 2020

Ciheb awarded $4 million to support COVID-19 response activities

The Center for International Health, Education and Biosecurity at the University of Maryland School of Medicine's Institute of Human Virology was awarded $4 million from the U.S. Centers for Disease Control and Prevention to support coronavirus disease 2019 (COVID-19) response activities in Botswana, Nigeria, Malawi, and Mozambique.

2 Jun 2020

HVTN and HPTN initiate first clinical trial in response to COVID-19

The NIH-funded HIV Vaccine Trials Network (HVTN) and HIV Prevention Trials Network (HPTN) have initiated their first clinical trial in response to COVID-19.

15 May 2020

ACTG initiates clinical trial to evaluate treatment for COVID-19

The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).

14 May 2020

New HIV vaccine better at preventing infection and offers more durable protection

Researchers from the Emory Consortium for Innovative AIDS Research in Nonhuman Primates and their colleagues across North America have shown a new HIV vaccine is better at preventing infection and lasts longer, continuing to protect one year after vaccination.

11 May 2020

Fred Hutch, NIH experts outline an efficient approach to creating COVID-19 vaccines

Unprecedented collaboration and resources will be required to research and develop safe and effective vaccines for COVID-19 that can be manufactured and delivered in the scale of billions of doses to people globally.

11 May 2020

Analysis: We knew the coronavirus was coming, yet we failed 5 critical tests

The arrival of COVID-19 has provided a nuclear-level stress test to the American health care system, and our grade isn't pretty: at least 73,000 dead, 1.2 million infected and 30 million unemployed; nursing homes, prisons and meatpacking plants that have become hotbeds of infection.

11 May 2020

WSU researchers crack the Lyme disease code

The next time a tick feeds on you, Washington State University researchers hope to make sure persistent arthritis caused by Lyme disease doesn't linger for a lifetime.

30 Apr 2020

Scientists launch clinical trial to test the efficacy of HIV drug against COVID-19 infection

A team of scientists from St. Michael's Hospital, Sinai Health and Sunnybrook Health Sciences Centre have launched a clinical trial to understand whether an existing drug used for HIV treatment and prevention may work to prevent COVID-19 infection.

28 Apr 2020

Fear, isolation and stigma attached to COVID-19 impact mental health of Africans

Fear, isolation and stigma are impacting the mental health of Africans during the COVID-19 pandemic, scientists say.

24 Apr 2020

The other COVID risks: How race, income, zip code influence who lives or dies

It started with a headache in late March. Then came the body aches.

22 Apr 2020

Gold-containing drug auranofin kills 95% of SARS-CoV-2 virus in 48 hours in lab conditions

A drug called auranofin, approved for the treatment of rheumatoid arthritis, effectively inhibits severe acute respiratory syndrome coronavirus (SARS-CoV-2) in laboratory conditions, as described in a new study by Georgia State University researchers.

16 Apr 2020

HIV/AIDS News and Research

Further Reading

UCLA receives nearly $14 million NIH grant to investigate immunotherapy to destroy HIV

Old antibiotic may be a powerful new tool against deadly superbug

KHN’s ‘What the Health?’: Protests and the pandemic

Ciheb awarded $4 million to support COVID-19 response activities

HVTN and HPTN initiate first clinical trial in response to COVID-19

ACTG initiates clinical trial to evaluate treatment for COVID-19

New HIV vaccine better at preventing infection and offers more durable protection

Fred Hutch, NIH experts outline an efficient approach to creating COVID-19 vaccines

Analysis: We knew the coronavirus was coming, yet we failed 5 critical tests

WSU researchers crack the Lyme disease code

Scientists launch clinical trial to test the efficacy of HIV drug against COVID-19 infection

Fear, isolation and stigma attached to COVID-19 impact mental health of Africans

The other COVID risks: How race, income, zip code influence who lives or dies

Gold-containing drug auranofin kills 95% of SARS-CoV-2 virus in 48 hours in lab conditions

Philadelphia Eagles owner contributes $1 million to Penn Medicine to fight COVID-19 pandemic

Study reveals the coronavirus camouflage that will aid vaccine design

Depressive disorders in patients with HIV/AIDS often go unrecognized or untreated

Deaths of Chinese children, adolescents from infectious diseases prior to COVID-19 found to be rare

COVID-19: Ban on eating wild meat deprives some forest communities

Newly developed laboratory model helps reveal how HIV infection affects the brain

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News